Dauri M, Costa F, Servetti S, Sidiropoulou T, Fabbi E, Sabato A F
Unit of Anesthesiology and Intensive Care, Tor Vergata University, Rome, Italy.
Minerva Anestesiol. 2003 Dec;69(12):873-84.
To evaluate the effectiveness and safety of epidural ropivacaine anesthesia in association with light general anesthesia during renal transplantation and compare epidural and endovenous analgesia techniques for postoperative pain control.
prospective randomized study.
Organ Transplantation Center, Department of Surgery, "Tor Vergata" University of Rome, St. Eugenio Hospital, Rome.
25 patients affected by chronic renal failure were enrolled in this study. Thirteen constituted the combined epidural-general anesthesia group (EPI-GEN), mean age 40.15+/-9.81 years; while the others constituted the general anesthesia group (GEN), mean age 46.75+/-7.45 years. Operation: cadaveric renal transplantation. Group EPI-GEN: epidural anesthesia performed with 12-15 ml of a ropivacaine 0.75% and fentanyl 5 microg/ml solution followed by light intravenous or inhalatory general anesthesia and postoperative epidural analgesia with ropivacaine 0.2% and fentanyl 2 mg/ml. Group GEN: inhalatory or intravenous general anesthesia and intravenous tramadol postoperative analgesia.
hemo-dynamics, renal function, arterial blood gases analysis, acid-base balance and postoperative pain data was collected and examined.
Postoperative epidural analgesia resulted significantly more effective than intravenous tramadol. PaO(2)/FiO(2) ratio was significantly higher in group EPI-GEN patients both on awakening and throughout postoperative observation. Hemodynamics and renal function did not appear to differ significantly.
Combined epidural-general anesthesia is as valid a technique as any for renal transplantation; however postoperative epidural ropivacaine analgesia resulted more effective than intravenous tramadol. Respiratory function appeared less affected, facilitating a fast and uncomplicated postoperative recovery.
评估肾移植术中硬膜外罗哌卡因麻醉联合浅全身麻醉的有效性和安全性,并比较硬膜外和静脉镇痛技术对术后疼痛的控制效果。
前瞻性随机研究。
罗马“托韦尔加塔”大学外科器官移植中心、罗马圣欧金尼奥医院。
25例慢性肾衰竭患者纳入本研究。13例组成硬膜外-全身联合麻醉组(EPI-GEN),平均年龄40.15±9.81岁;其余组成全身麻醉组(GEN),平均年龄46.75±7.45岁。手术:尸体肾移植。EPI-GEN组:采用12 - 15 ml 0.75%罗哌卡因和5 μg/ml芬太尼溶液进行硬膜外麻醉,随后行浅静脉或吸入全身麻醉,术后采用0.2%罗哌卡因和2 μg/ml芬太尼进行硬膜外镇痛。GEN组:采用吸入或静脉全身麻醉,术后静脉注射曲马多镇痛。
收集并检查血流动力学、肾功能、动脉血气分析、酸碱平衡及术后疼痛数据。
术后硬膜外镇痛效果明显优于静脉注射曲马多。EPI-GEN组患者苏醒时及术后整个观察期的PaO₂/FiO₂比值均显著更高。血流动力学和肾功能未见明显差异。
硬膜外-全身联合麻醉是肾移植的有效技术之一;然而,术后硬膜外罗哌卡因镇痛效果优于静脉注射曲马多。呼吸功能受影响较小,有利于术后快速、顺利恢复。